Molecular Design of Conjugated Tumor Necrosis Factor-α: Synthesis and Characteristics of Polyvinyl Pyrrolidone Modified Tumor Necrosis Factor-α
- 1 April 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 257 (2) , 448-453
- https://doi.org/10.1006/bbrc.1999.0353
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
- Japan Society for the Promotion of Science
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 16 references indexed in Scilit:
- Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γNature Medicine, 1998
- Polyethylene glycol modification of interleukin-6 enhances its thrombopoietic activityJournal of Controlled Release, 1995
- Characterization of PEG-IL-6 and its thrombopoietic activity in vivo.Drug Delivery System, 1995
- lnterleukin-12International Archives of Allergy and Immunology, 1995
- Phase I study of recombinant human tumor necrosis factorCancer Chemotherapy and Pharmacology, 1987
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.The Journal of Experimental Medicine, 1986
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.Proceedings of the National Academy of Sciences, 1985
- Effect of tumour necrosis factor on cultured human melanoma cellsNature, 1975
- Divinyl Ether-Maleic Anhydride (Pyran) Copolymer used to demonstrate the Effect of Molecular Weight on Biological ActivityNature, 1973